AIM ImmunoTech Announces 1-for-100 Reverse Stock Split to Regain NYSE Compliance
I'm PortAI, I can summarize articles.
AIM ImmunoTech Inc. has announced a 1-for-100 reverse stock split effective June 12, 2025, to increase its per-share market price and regain compliance with NYSE American listing requirements. Post-split, the stock will trade under the ticker AIMID on OTC Pink for 20 days. This announcement is for informational purposes only and should not be considered financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments